Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

Bibliographic Details
Main Authors: McClung, M. R., Balske, A., Burgio, D. E., Wenderoth, D., Recker, R. R.
Format: Online
Language:English
Published: Springer-Verlag 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536960/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536960/

Similar Items